About
TT3A is an innovative Italy-based MedTech startup pioneering the development of the world's first medical device specifically designed for the endovascular treatment of ascending aortic aneurysms and dissections. Currently advancing into the pre-clinical phase, we aim to demonstrate in-vivo feasibility, efficacy, and safety, setting the stage for transformative solutions in aortic care.
Technologies
Gmail
Google Apps
Apache
Mobile Friendly
Keywords
medical equipment manufacturing
european regional development fund
endovascular prosthesis
medical device
innovative medical device
investment funding
recovery time reduction
aortic pathologies
revolutionary aortology device
patient outcomes
ataads treatment
percutaneous approach
minimally invasive treatment
advanced device design
endovascular therapy
device development
fully transcatheter device
medical devices
percutaneous repair
transcatheter treatment
transcatheter aortic repair
regional co-financing
feasibility studies
biotechnology
medical innovation
healthcare
patient safety
innovative prosthesis
risk assessment
device design
Company Information
-
Employees 4
-
Founded 2022
Location
Viale Ortles, Milan, Lombardy, Italy, 20139
